Conatus Pharmaceuticals (CNAT)

Add to Watchlists
Create an Alert
3.83 +0.15  +4.08% NASDAQ Aug 28, 10:44 Delayed 2m USD
View Full Chart
CNAT Price Chart
View All Performance Charts

CNAT Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Conatus Pharmaceuticals is down 44.25% over the last year vs S&P 500 Total Return up 1.49%, Arena Pharmaceuticals down 36.49%, and Corcept Therapeutics up 75.17%.


CNAT Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website:
  • IR Website:
  • HQ Country: United States
  • HQ State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: September 30, 2015
  • Est. Current Fiscal Year End: December 31, 2015
  • Last Fiscal Quarter End: June 30, 2015
  • Last Fiscal Year End: December 31, 2014
  • Next Earnings Release: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Conatus Pharmaceuticals Inc is a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease.

CNAT Excel Add-In Codes

  • Name: =YCI("CNAT","name")
  • Description: =YCI("CNAT","description")
  • Sector: =YCI("CNAT","sector")
  • Industry: =YCI("CNAT","industry")
  • Est. Current Fiscal Year End: =YCI("CNAT","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.


You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.


Start your free 7-Day Trial.

{{}} No credit card required.

Already a subscriber? Sign in.